Who owns GSK plc?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of GSK from SEC Form 13F filings across 987 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 987 institutions disclosed 331.9M shares of GSK plc worth $16.00B — about 16.4% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
987
13F holders
$16.00B
value, 2026 filers
16.4%
of shares outstanding (331.9M sh)
82
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of GSK's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 64.9M | $3.13B | 0.1% | 3.2% | -0.1% |
| 2 | Dodge & Cox | 43.2M | $2.08B | 1.1% | 2.1% | -10.4% |
| 3 | Fisher Asset Management, LLC | 35.4M | $1.70B | 0.5% | 1.7% | -1.0% |
| 4 | PRIMECAP MANAGEMENT CO/CA/ | 25.2M | $1.21B | 0.8% | 1.2% | 0.0% |
| 5 | WELLINGTON MANAGEMENT GROUP LLP | 9.7M | $464.9M | 0.1% | 0.5% | -15.3% |
| 6 | JTC Employer Solutions Trustee Ltd | 8.1M | $389.2M | 33.5% | 0.4% | -6.0% |
| 7 | ROYAL BANK OF CANADA | 7.7M | $368.6M | 0.1% | 0.4% | +0.8% |
| 8 | MORGAN STANLEY | 7.6M | $365.4M | 0.0% | 0.4% | -1.0% |
| 9 | PRICE T ROWE ASSOCIATES INC /MD/ | 6.7M | $323.3M | 0.0% | 0.3% | -3.1% |
| 10 | GOLDMAN SACHS GROUP INC | 6.0M | $290.1M | 0.0% | 0.3% | -5.5% |
| 11 | STATE STREET CORP | 5.9M | $288.8M | 0.0% | 0.3% | -0.3% |
| 12 | Mondrian Investment Partners LTD | 5.0M | $239.2M | 4.4% | 0.2% | +1.1% |
| 13 | ACADIAN ASSET MANAGEMENT LLC | 4.6M | $219.4M | 0.3% | 0.2% | -31.6% |
| 14 | HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 3.9M | $188.8M | 0.5% | 0.2% | +14.8% |
| 15 | Grantham, Mayo, Van Otterloo & Co. LLC | 3.9M | $188.7M | 0.4% | 0.2% | +8.8% |
| 16 | EQUITY INVESTMENT CORP | 3.6M | $171.5M | 3.2% | 0.2% | +8.9% |
| 17 | BlackRock, Inc. | 3.4M | $164.2M | 0.0% | 0.2% | -5.8% |
| 18 | DIMENSIONAL FUND ADVISORS LP | 2.8M | $133.3M | 0.0% | 0.1% | +2.8% |
| 19 | UBS Group AG | 2.2M | $104.8M | 0.0% | 0.1% | -22.5% |
| 20 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2.2M | $104.5M | 0.0% | 0.1% | +32.8% |
| 21 | BANK OF AMERICA CORP /DE/ | 2.2M | $104.2M | 0.0% | 0.1% | -2.5% |
| 22 | Connor, Clark & Lunn Investment Management Ltd. | 2.1M | $99.9M | 0.2% | 0.1% | -25.1% |
| 23 | BANK OF MONTREAL /CAN/ | 2.0M | $97.5M | 0.0% | 0.1% | -50.0% |
| 24 | ENVESTNET ASSET MANAGEMENT INC | 2.0M | $97.1M | 0.0% | 0.1% | +5.6% |
| 25 | D. E. Shaw & Co., Inc. | 2.0M | $94.1M | 0.0% | 0.1% | +91.7% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.